C

CorMedix

D
CRMD
USD
-0.245
(-3.3793%)
Market Closed
42,396.00
Volume
-0.37
EPS
-
Div Yield
-7.608696
P/E
391,299,047.82
Market Cap
Today
-3.3793%
1 Week
2.188%
1 Month
35.756%
6 Months
82.898%
12 Months
84.585%
Year To Date
85.809%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
AMGN
AMGN
3.02
(0.9071%)
USD
MRK
MRK
-1.44
(-1.2137%)
USD
PFE
PFE
-0.09
(-0.3025%)
USD
GILD
GILD
0.015
(0.0179%)
USD
NVS
NVS
-0.02
(-0.0172%)
USD
BMY
BMY
-0.72
(-1.4475%)
USD
JNJ
JNJ
-1.31
(-0.7883%)
USD
LLY
LLY
10.49
(1.1589%)
USD

Title:
CorMedix

Sector:
Healthcare
Industry:
Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Do you need help or have a question?
Contact Us